RAPT Therapeutics (RAPT) Short-term Investments (2020 - 2024)
Historic Short-term Investments for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to $60.0 million.
- Therapeutics' Short-term Investments fell 5406.91% to $60.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $60.0 million, marking a year-over-year decrease of 5406.91%. This contributed to the annual value of $111.4 million for FY2023, which is 4699.08% down from last year.
- Latest data reveals that Therapeutics reported Short-term Investments of $60.0 million as of Q3 2024, which was down 5406.91% from $77.8 million recorded in Q2 2024.
- Therapeutics' Short-term Investments' 5-year high stood at $210.1 million during Q4 2022, with a 5-year trough of $46.7 million in Q1 2020.
- Its 5-year average for Short-term Investments is $123.8 million, with a median of $130.6 million in 2023.
- Its Short-term Investments has fluctuated over the past 5 years, first surged by 9127.29% in 2021, then plummeted by 5406.91% in 2024.
- Therapeutics' Short-term Investments (Quarter) stood at $86.6 million in 2020, then surged by 91.27% to $165.6 million in 2021, then rose by 26.86% to $210.1 million in 2022, then tumbled by 46.99% to $111.4 million in 2023, then crashed by 46.13% to $60.0 million in 2024.
- Its Short-term Investments stands at $60.0 million for Q3 2024, versus $77.8 million for Q2 2024 and $96.3 million for Q1 2024.